Fisher Asset Management’s Theriva Biologics TOVX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,569	Closed	-$6.78K	–	1121
2023 Q3	$6.78K	Hold	12,569	–	–	﹤0.01%	1108
2023 Q2	$12.6K	Hold	12,569	–	–	﹤0.01%	1094
2023 Q1	$8.78K	Hold	12,569	–	–	﹤0.01%	1059
2022 Q4	$6K	Hold	12,569	–	–	﹤0.01%	1024
2022 Q3	$12K	Sell	12,569 -113,129	-90%	-$108K	﹤0.01%	923
2022 Q2	$27K	Hold	125,698	–	–	﹤0.01%	892
2022 Q1	$36K	Hold	125,698	–	–	﹤0.01%	921
2021 Q4	$34K	Hold	125,698	–	–	﹤0.01%	947
2021 Q3	$58K	Hold	125,698	–	–	﹤0.01%	906
2021 Q2	$76K	Sell	125,698 -2,000	-2%	-$1.21K	﹤0.01%	902
2021 Q1	$87K	Buy	127,698 +2,000	+2%	+$1.36K	﹤0.01%	886
2020 Q4	$48K	Buy	125,698 +65,370	+108%	+$25K	﹤0.01%	899
2020 Q3	$29K	Hold	60,328	–	–	﹤0.01%	840
2020 Q2	$31K	Buy	+60,328	New	+$31K	﹤0.01%	800
2018 Q3	–	Sell	-133,967	Closed	-$32K	–	848
2018 Q2	$32K	Hold	133,967	–	–	﹤0.01%	796
2018 Q1	$43K	Hold	133,967	–	–	﹤0.01%	750
2017 Q4	$68K	Hold	133,967	–	–	﹤0.01%	855
2017 Q3	$125K	Hold	133,967	–	–	﹤0.01%	770
2017 Q2	$76K	Hold	133,967	–	–	﹤0.01%	738
2017 Q1	$84K	Hold	133,967	–	–	﹤0.01%	710
2016 Q4	$102K	Buy	133,967 +83,967	+168%	+$63.9K	﹤0.01%	711
2016 Q3	$86K	Buy	50,000 +25,000	+100%	+$43K	﹤0.01%	710
2016 Q2	$46K	Buy	25,000 +14,500	+138%	+$26.7K	﹤0.01%	687
2016 Q1	$29K	Hold	10,500	–	–	﹤0.01%	683
2015 Q4	$24K	Hold	10,500	–	–	﹤0.01%	732
2015 Q3	$24K	Buy	+10,500	New	+$24K	﹤0.01%	663